The difference in vascularity between the BBB and the BTB may provide a therapeutic window where certain drugs can selectively increase the permeability in brain tumor capillaries, without causing ...

Of the patients who completed the initial MRI, 14% had brain metastasis. The rates by subtype were: 18% in triple-negative breast cancer 15% in HER2-positive breast cancer 10% in hormone receptor ...

Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...

In general, triple-negative breast cancers and HER2-amplified breast cancers are most likely to recur compared to luminal A breast cancers (estrogen receptor-positive ... and/or MRI is done ...

MEDSIR, a global company dedicated to independent clinical research in oncology, has initiated the PHERGain II clinical trial to demonstrate that in patients with HER2-positive early breast cancer ...